U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Cambiar Investors LLC

Cambiar Investors LLC raised its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 31.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,655 shares of the company’s stock after acquiring an additional 6,350 shares during the quarter. Cambiar Investors LLC owned 0.18% of U.S. Physical Therapy worth $2,256,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in USPH. Semanteon Capital Management LP purchased a new position in U.S. Physical Therapy in the third quarter valued at about $776,000. International Assets Investment Management LLC raised its position in shares of U.S. Physical Therapy by 8,414.8% in the 3rd quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock valued at $195,000 after purchasing an additional 2,272 shares in the last quarter. Precision Wealth Strategies LLC raised its position in shares of U.S. Physical Therapy by 5.1% in the 3rd quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock valued at $239,000 after purchasing an additional 137 shares in the last quarter. Penn Davis Mcfarland Inc. purchased a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at approximately $2,552,000. Finally, NBC Securities Inc. grew its position in shares of U.S. Physical Therapy by 8.0% during the third quarter. NBC Securities Inc. now owns 8,523 shares of the company’s stock worth $721,000 after buying an additional 633 shares in the last quarter.

Insider Buying and Selling

In other news, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the transaction, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

USPH has been the subject of several recent analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America reissued a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th.

U.S. Physical Therapy Trading Up 1.5 %

NYSE USPH opened at $81.38 on Friday. The firm has a market capitalization of $1.23 billion, a PE ratio of 76.77, a price-to-earnings-growth ratio of 3.81 and a beta of 1.38. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The company has a 50-day simple moving average of $83.03 and a 200-day simple moving average of $91.95. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The company had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same period last year, the business posted $0.76 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 annualized dividend and a dividend yield of 2.16%. U.S. Physical Therapy’s dividend payout ratio is currently 166.04%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.